Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
MAS1 proto-oncogene like, G protein-coupled receptor (MAS1L) is a member of the G protein-coupled receptor (GPCR) superfamily characterized by seven transmembrane domains[5]. It is predicted to have G protein-coupled receptor activity and to be involved in GPCR signaling pathways, which play crucial roles in cellular signal transduction by responding to external signals and activating intracellular signaling cascades[5][1][2]. MAS1L is localized in the cytosol, nucleoplasm, and plasma membrane[5]. While its precise endogenous ligands, detailed biological functions, and disease associations remain largely uncharacterized, MAS1L is considered a putative receptor target based on its structure and domain architecture[5]. According to current databases, there is no strong evidence directly linking MAS1L to particular approved drugs or established roles as a disease biomarker or therapeutic target in common diseases.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on MAS1 proto-oncogene like, G protein-coupled receptor (MAS1L).